Izalontamab Brengitecan (iza-bren) in Patients with Pretreated Advanced Hepatocellular Carcinoma (HCC): Results from Two Phase I/II Studies (ESMO Asia 2026) - Oct 1, 2026 - Abstract #238O; Pres time: Dec 4, 2026; 10:55 AM - 11:05 AM; Location: Hall 402; No abstract available
Clinical • Metastases • P1/2 data • Hepatocellular Cancer • Oncology • Solid Tumor
|